CRWD CrowdStrike | $191.95 +0.8% | 8/20/2026 | | Reiterated Rating | | Neutral | 00.00% | View details for Guggenheim rating of CrowdStrike (NASDAQ:CRWD) on 8/20/2026 |
OKTA Okta | $135.14 +0.7% | 8/20/2026 | | Boost Price Target | $138.00 ➝ $162.00 | Buy | 00.00% | View details for Guggenheim rating of Okta (NASDAQ:OKTA) on 8/20/2026 |
TGT Target | $165.35 +4.5% | 8/20/2026 | | Boost Price Target | $150.00 ➝ $175.00 | Buy | 00.00% | View details for Guggenheim rating of Target (NYSE:TGT) on 8/20/2026 |
VEEV Veeva Systems | $248.26 -0.9% | 8/20/2026 | | Boost Price Target | $232.00 ➝ $276.00 | Buy | 00.00% | View details for Guggenheim rating of Veeva Systems (NYSE:VEEV) on 8/20/2026 |
FRNM Freenome | $13.81 +2.2% | 8/20/2026 | | Initiated Coverage | $21.00 | Buy | 00.00% | View details for Guggenheim rating of Freenome (NASDAQ:FRNM) on 8/20/2026 |
ADSK Autodesk | $253.82 +1.1% | 8/20/2026 | | Boost Price Target | $245.00 ➝ $277.00 | Buy | 00.00% | View details for Guggenheim rating of Autodesk (NASDAQ:ADSK) on 8/20/2026 |
S SentinelOne | $21.20 +1.2% | 8/20/2026 | | Boost Price Target | $24.00 ➝ $28.00 | Buy | 00.00% | View details for Guggenheim rating of SentinelOne (NYSE:S) on 8/20/2026 |
CRM Salesforce | $209.20 +1.8% | 8/20/2026 | | Reiterated Rating | $228.00 | Buy | 00.00% | View details for Guggenheim rating of Salesforce (NYSE:CRM) on 8/20/2026 |
FRNM Freenome | $13.81 +2.2% | 8/20/2026 | | Initiated Coverage | $21.00 | Buy | 00.00% | View details for Guggenheim rating of Freenome (NASDAQ:FRNM) on 8/20/2026 |
GTLB GitLab | $41.67 -1.0% | 8/19/2026 | | Reiterated Rating | | Neutral | 00.00% | View details for Guggenheim rating of GitLab (NASDAQ:GTLB) on 8/19/2026 |
Get the Latest News and Ratings for Your Stocks Enter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter.
|
AMLX Amylyx Pharmaceuticals | $38.66 -2.5% | 8/19/2026 | | Boost Price Target | $40.00 ➝ $55.00 | Buy | 00.00% | View details for Guggenheim rating of Amylyx Pharmaceuticals (NASDAQ:AMLX) on 8/19/2026 |
ESTC Elastic | $85.91 +0.0% | 8/19/2026 | | Reiterated Rating | $106.00 | Buy | 00.00% | View details for Guggenheim rating of Elastic (NYSE:ESTC) on 8/19/2026 |
HD Home Depot | $336.04 +0.5% | 8/19/2026 | | Reiterated Rating | $425.00 | Buy | 00.00% | View details for Guggenheim rating of Home Depot (NYSE:HD) on 8/19/2026 |
SCTX Scribe Therapeutics | $34.13 +4.0% | 8/18/2026 | | Initiated Coverage | $50.00 | Buy | 00.00% | View details for Guggenheim rating of Scribe Therapeutics (NASDAQ:SCTX) on 8/18/2026 |
MDB MongoDB | $430.83 +2.5% | 8/18/2026 | | Boost Price Target | $475.00 ➝ $560.00 | Buy | 00.00% | View details for Guggenheim rating of MongoDB (NASDAQ:MDB) on 8/18/2026 |
LGN LGN | $59.37 -1.2% | 8/18/2026 | | Reiterated Rating | $115.00 | Buy | 00.00% | View details for Guggenheim rating of LGN (NASDAQ:LGN) on 8/18/2026 |
SCTX Scribe Therapeutics | $34.13 +4.0% | 8/18/2026 | | Initiated Coverage | $50.00 | Buy | 00.00% | View details for Guggenheim rating of Scribe Therapeutics (NASDAQ:SCTX) on 8/18/2026 |
CELC Celcuity | $93.53 +3.3% | 8/17/2026 | | Boost Price Target | $165.00 ➝ $175.00 | Buy | 00.00% | View details for Guggenheim rating of Celcuity (NASDAQ:CELC) on 8/17/2026 |
SPRB Spruce Biosciences | $51.58 -0.8% | 8/17/2026 | | Reiterated Rating | $123.00 ➝ $104.00 | Buy | 00.00% | View details for Guggenheim rating of Spruce Biosciences (NASDAQ:SPRB) on 8/17/2026 |
WMT Walmart | $103.70 -0.1% | 8/17/2026 | | Reiterated Rating | $137.00 ➝ $135.00 | Buy | 00.00% | View details for Guggenheim rating of Walmart (NASDAQ:WMT) on 8/17/2026 |
YSWY Yesway | $25.20 +2.4% | 8/17/2026 | | Boost Price Target | $30.00 ➝ $32.00 | Buy | 00.00% | View details for Guggenheim rating of Yesway (NASDAQ:YSWY) on 8/17/2026 |
ADCT ADC Therapeutics | $1.00 +3.9% | 8/17/2026 | | Lower Price Target | $5.00 | Buy | 00.00% | View details for Guggenheim rating of ADC Therapeutics (NYSE:ADCT) on 8/17/2026 |
FWONK Liberty Media Corporation - Liberty Formula One Series C | $104.94 +0.7% | 8/17/2026 | | Boost Price Target | $125.00 ➝ $134.00 | Buy | 00.00% | View details for Guggenheim rating of Liberty Media Corporation - Liberty Formula One Series C (NASDAQ:FWONK) on 8/17/2026 |
FWONA Liberty Media Corporation - Liberty Formula One Series A | $96.52 +1.0% | 8/14/2026 | | Boost Price Target | $116.00 ➝ $124.00 | Buy | 00.00% | View details for Guggenheim rating of Liberty Media Corporation - Liberty Formula One Series A (NASDAQ:FWONA) on 8/14/2026 |
BIRK Birkenstock | $35.67 +3.2% | 8/14/2026 | | Reiterated Rating | $60.00 | Buy | 00.00% | View details for Guggenheim rating of Birkenstock (NYSE:BIRK) on 8/14/2026 |
GLOB Globant | $39.66 +0.1% | 8/14/2026 | | Lower Price Target | $55.00 ➝ $50.00 | Buy | 00.00% | View details for Guggenheim rating of Globant (NYSE:GLOB) on 8/14/2026 |
MSGS Madison Square Garden | $407.48 +2.2% | 8/14/2026 | | Boost Price Target | $522.00 ➝ $584.00 | Buy | 00.00% | View details for Guggenheim rating of Madison Square Garden (NYSE:MSGS) on 8/14/2026 |
ZBIO Zenas BioPharma | $32.29 +2.1% | 8/14/2026 | | Reiterated Rating | $55.00 | Buy | 00.00% | View details for Guggenheim rating of Zenas BioPharma (NASDAQ:ZBIO) on 8/14/2026 |
PHVS Pharvaris | $36.27 -0.3% | 8/13/2026 | | Boost Price Target | $39.00 ➝ $40.00 | Buy | 00.00% | View details for Guggenheim rating of Pharvaris (NASDAQ:PHVS) on 8/13/2026 |
UNCY Unicycive Therapeutics | $5.63 +3.3% | 8/13/2026 | | Reiterated Rating | $37.00 ➝ $25.00 | Buy | 00.00% | View details for Guggenheim rating of Unicycive Therapeutics (NASDAQ:UNCY) on 8/13/2026 |
ERAS Erasca | $17.63 +3.2% | 8/13/2026 | | Boost Price Target | $20.00 ➝ $21.00 | Buy | 00.00% | View details for Guggenheim rating of Erasca (NASDAQ:ERAS) on 8/13/2026 |
P Everpure | $108.51 -1.3% | 8/13/2026 | | Boost Price Target | $115.00 ➝ $150.00 | Buy | 00.00% | View details for Guggenheim rating of Everpure (NYSE:P) on 8/13/2026 |
SCYX SCYNEXIS | $5.10 -2.3% | 8/13/2026 | | Reiterated Rating | $24.00 ➝ $33.00 | Buy | 00.00% | View details for Guggenheim rating of SCYNEXIS (NASDAQ:SCYX) on 8/13/2026 |
CAVA CAVA Group | $73.64 +2.2% | 8/13/2026 | | Lower Price Target | $100.00 ➝ $95.00 | Buy | 00.00% | View details for Guggenheim rating of CAVA Group (NYSE:CAVA) on 8/13/2026 |
STUB STUB | $6.73 -1.5% | 8/13/2026 | | Lower Price Target | $12.50 ➝ $11.00 | Buy | 00.00% | View details for Guggenheim rating of STUB (NYSE:STUB) on 8/13/2026 |
AVBP ArriVent BioPharma | $29.12 -0.2% | 8/13/2026 | | Reiterated Rating | $45.00 | Buy | 00.00% | View details for Guggenheim rating of ArriVent BioPharma (NASDAQ:AVBP) on 8/13/2026 |
MSGE Madison Square Garden Entertainment | $79.99 +0.2% | 8/12/2026 | | Boost Price Target | $82.00 ➝ $103.00 | Buy | 00.00% | View details for Guggenheim rating of Madison Square Garden Entertainment (NYSE:MSGE) on 8/12/2026 |
COGT Cogent Biosciences | $36.73 +4.0% | 8/12/2026 | | Boost Price Target | $45.00 ➝ $52.00 | Buy | 00.00% | View details for Guggenheim rating of Cogent Biosciences (NASDAQ:COGT) on 8/12/2026 |
NGNE Neurogene | $38.63 +1.7% | 8/12/2026 | | Boost Price Target | $69.00 ➝ $81.00 | Buy | 00.00% | View details for Guggenheim rating of Neurogene (NASDAQ:NGNE) on 8/12/2026 |
ZURA Zura Bio | $5.85 +1.7% | 8/12/2026 | | Boost Price Target | $15.00 ➝ $20.00 | Buy | 00.00% | View details for Guggenheim rating of Zura Bio (NASDAQ:ZURA) on 8/12/2026 |
Trump's New Dollar (Ad) Porter Stansberry says President Trump has signed an executive order initiating what he calls a full U.S. dollar reset - and most Americans don't know it's happening.
The last time America underwent a monetary shift like this, under Nixon in the 1970s, it minted an average of 1,300 new millionaires a day for over half a century. Stansberry has released a new documentary naming the assets he believes are positioned to surge as a result. Watch the free briefing and see the three steps to prepare today |
TNGX Tango Therapeutics | $23.88 +1.6% | 8/12/2026 | | Boost Price Target | $32.00 ➝ $35.00 | Buy | 00.00% | View details for Guggenheim rating of Tango Therapeutics (NASDAQ:TNGX) on 8/12/2026 |
NTRA Natera | $332.03 +2.2% | 8/12/2026 | | Boost Price Target | $290.00 ➝ $360.00 | Buy | 00.00% | View details for Guggenheim rating of Natera (NASDAQ:NTRA) on 8/12/2026 |
LTH Life Time Group | $45.15 +1.0% | 8/12/2026 | | Reiterated Rating | $50.00 | Buy | 00.00% | View details for Guggenheim rating of Life Time Group (NYSE:LTH) on 8/12/2026 |
AXSM Axsome Therapeutics | $207.77 -0.1% | 8/11/2026 | | Boost Price Target | $260.00 ➝ $275.00 | Buy | 00.00% | View details for Guggenheim rating of Axsome Therapeutics (NASDAQ:AXSM) on 8/11/2026 |
SEPN Septerna | $40.00 -1.9% | 8/11/2026 | | Boost Price Target | $45.00 ➝ $51.00 | Buy | 00.00% | View details for Guggenheim rating of Septerna (NASDAQ:SEPN) on 8/11/2026 |
TENX Tenax Therapeutics | $1.75 -1.7% | 8/11/2026 | | Set Price Target | $40.00 ➝ $4.00 | Buy | 00.00% | View details for Guggenheim rating of Tenax Therapeutics (NASDAQ:TENX) on 8/11/2026 |
TENX Tenax Therapeutics | $1.75 -1.7% | 8/11/2026 | | Reiterated Rating | $40.00 ➝ $4.00 | Buy | 00.00% | View details for Guggenheim rating of Tenax Therapeutics (NASDAQ:TENX) on 8/11/2026 |
ORKA Oruka Therapeutics | $107.96 +3.0% | 8/11/2026 | | Reiterated Rating | $200.00 | Buy | 00.00% | View details for Guggenheim rating of Oruka Therapeutics (NASDAQ:ORKA) on 8/11/2026 |
CTMX CytomX Therapeutics | $3.28 -0.3% | 8/10/2026 | | Lower Price Target | $15.00 ➝ $14.00 | Buy | 00.00% | View details for Guggenheim rating of CytomX Therapeutics (NASDAQ:CTMX) on 8/10/2026 |
EPAM EPAM Systems | $110.49 +3.5% | 8/10/2026 | | Lower Price Target | $165.00 ➝ $140.00 | Buy | 00.00% | View details for Guggenheim rating of EPAM Systems (NYSE:EPAM) on 8/10/2026 |
AMGN Amgen | $439.33 +1.3% | 8/10/2026 | | Boost Price Target | $343.00 ➝ $388.00 | Neutral | 00.00% | View details for Guggenheim rating of Amgen (NASDAQ:AMGN) on 8/10/2026 |
ANIP ANI Pharmaceuticals | $75.35 -2.5% | 8/10/2026 | | Lower Price Target | $124.00 ➝ $119.00 | Buy | 00.00% | View details for Guggenheim rating of ANI Pharmaceuticals (NASDAQ:ANIP) on 8/10/2026 |
DKNG DraftKings | $26.17 +4.6% | 8/10/2026 | | Lower Price Target | $35.00 ➝ $33.00 | Buy | 00.00% | View details for Guggenheim rating of DraftKings (NASDAQ:DKNG) on 8/10/2026 |
SERV Serve Robotics | $4.98 +5.1% | 8/10/2026 | | Lower Price Target | $13.00 ➝ $7.00 | Buy | 00.00% | View details for Guggenheim rating of Serve Robotics (NASDAQ:SERV) on 8/10/2026 |
SION Sionna Therapeutics | $5.29 -4.2% | 8/10/2026 | | Downgrade | | Buy ➝ Neutral | 00.00% | View details for Guggenheim rating of Sionna Therapeutics (NASDAQ:SION) on 8/10/2026 |
SPCX SpaceX | $136.97 +2.2% | 8/7/2026 | | Initiated Coverage | | Buy | 00.00% | View details for Guggenheim rating of SpaceX (NASDAQ:SPCX) on 8/7/2026 |
AVTX Avalo Therapeutics | $19.83 +0.1% | 8/7/2026 | | Set Price Target | $50.00 ➝ $48.00 | Buy | 00.00% | View details for Guggenheim rating of Avalo Therapeutics (NASDAQ:AVTX) on 8/7/2026 |
SION Sionna Therapeutics | $5.29 -4.2% | 8/7/2026 | | Boost Price Target | $50.00 ➝ $60.00 | Buy | 00.00% | View details for Guggenheim rating of Sionna Therapeutics (NASDAQ:SION) on 8/7/2026 |
GHRS GH Research | $28.33 -1.2% | 8/7/2026 | | Boost Price Target | $34.00 ➝ $40.00 | Buy | 00.00% | View details for Guggenheim rating of GH Research (NASDAQ:GHRS) on 8/7/2026 |
GLUE Monte Rosa Therapeutics | $14.30 -3.2% | 8/7/2026 | | Lower Price Target | $35.00 ➝ $28.00 | Buy | 00.00% | View details for Guggenheim rating of Monte Rosa Therapeutics (NASDAQ:GLUE) on 8/7/2026 |
INSM Insmed | $125.77 +0.6% | 8/7/2026 | | Lower Price Target | $207.00 ➝ $205.00 | Buy | 00.00% | View details for Guggenheim rating of Insmed (NASDAQ:INSM) on 8/7/2026 |
PFE Pfizer | $28.00 +0.8% | 8/7/2026 | | Lower Price Target | $35.00 ➝ $31.00 | Buy | 00.00% | View details for Guggenheim rating of Pfizer (NYSE:PFE) on 8/7/2026 |
ETSY Etsy | $80.69 -0.6% | 8/7/2026 | | Boost Price Target | $85.00 ➝ $95.00 | Buy | 00.00% | View details for Guggenheim rating of Etsy (NYSE:ETSY) on 8/7/2026 |
JANX Janux Therapeutics | $17.39 +0.6% | 8/7/2026 | | Lower Price Target | $58.00 ➝ $55.00 | Buy | 00.00% | View details for Guggenheim rating of Janux Therapeutics (NASDAQ:JANX) on 8/7/2026 |
FROG JFrog | $92.13 +2.7% | 8/7/2026 | | Boost Price Target | $105.00 ➝ $115.00 | Buy | 00.00% | View details for Guggenheim rating of JFrog (NASDAQ:FROG) on 8/7/2026 |
CYRX CryoPort | $17.13 +2.5% | 8/7/2026 | | Boost Price Target | $12.00 ➝ $16.00 | Buy | 00.00% | View details for Guggenheim rating of CryoPort (NASDAQ:CYRX) on 8/7/2026 |
VSTM Verastem | $6.89 +1.0% | 8/7/2026 | | Set Price Target | $14.00 ➝ $12.00 | Buy | 00.00% | View details for Guggenheim rating of Verastem (NASDAQ:VSTM) on 8/7/2026 |
TEAM Atlassian | $171.81 -1.8% | 8/7/2026 | | Boost Price Target | $115.00 ➝ $165.00 | Buy | 00.00% | View details for Guggenheim rating of Atlassian (NASDAQ:TEAM) on 8/7/2026 |
NET Cloudflare | $293.16 +5.1% | 8/7/2026 | | Boost Price Target | $140.00 ➝ $160.00 | Sell | 00.00% | View details for Guggenheim rating of Cloudflare (NYSE:NET) on 8/7/2026 |
ROKU Roku | $157.49 +0.2% | 8/7/2026 | | Downgrade | $145.00 ➝ $160.00 | Buy ➝ Neutral | 00.00% | View details for Guggenheim rating of Roku (NASDAQ:ROKU) on 8/7/2026 |
XPOF Xponential Fitness | $5.17 +2.2% | 8/7/2026 | | Downgrade | | Buy ➝ Neutral | 00.00% | View details for Guggenheim rating of Xponential Fitness (NYSE:XPOF) on 8/7/2026 |
USFD US Foods | $109.52 +1.0% | 8/7/2026 | | Boost Price Target | $115.00 ➝ $120.00 | Buy | 00.00% | View details for Guggenheim rating of US Foods (NYSE:USFD) on 8/7/2026 |
TTD Trade Desk | $13.18 -1.1% | 8/7/2026 | | Downgrade | $25.00 ➝ $12.00 | Buy ➝ Neutral | 00.00% | View details for Guggenheim rating of Trade Desk (NASDAQ:TTD) on 8/7/2026 |
TTD Trade Desk | $13.18 -1.1% | 8/7/2026 | | Set Price Target | $25.00 ➝ $12.00 | Buy ➝ Neutral | 00.00% | View details for Guggenheim rating of Trade Desk (NASDAQ:TTD) on 8/7/2026 |
RLAY Relay Therapeutics | $19.44 -1.3% | 8/7/2026 | | Reiterated Rating | | Buy | 00.00% | View details for Guggenheim rating of Relay Therapeutics (NASDAQ:RLAY) on 8/7/2026 |
AKAM Akamai Technologies | $110.42 +0.3% | 8/7/2026 | | Boost Price Target | $181.00 ➝ $190.00 | Buy | 00.00% | View details for Guggenheim rating of Akamai Technologies (NASDAQ:AKAM) on 8/7/2026 |
CART Maplebear | $49.83 -2.4% | 8/7/2026 | | Boost Price Target | $44.00 ➝ $46.00 | Neutral | 00.00% | View details for Guggenheim rating of Maplebear (NASDAQ:CART) on 8/7/2026 |
FWRG First Watch Restaurant Group | $13.03 +3.2% | 8/7/2026 | | Lower Price Target | $21.00 ➝ $20.00 | Buy | 00.00% | View details for Guggenheim rating of First Watch Restaurant Group (NASDAQ:FWRG) on 8/7/2026 |
GMAB Genmab A/S | $33.45 +0.1% | 8/7/2026 | | Boost Price Target | $40.00 ➝ $42.00 | Buy | 00.00% | View details for Guggenheim rating of Genmab A/S (NASDAQ:GMAB) on 8/7/2026 |
ROIV Roivant Sciences | $36.30 -1.5% | 8/7/2026 | | Boost Price Target | $36.00 ➝ $42.00 | Buy | 00.00% | View details for Guggenheim rating of Roivant Sciences (NASDAQ:ROIV) on 8/7/2026 |
ZVRA Zevra Therapeutics | $11.87 -0.2% | 8/7/2026 | | Lower Price Target | $24.00 ➝ $23.00 | Buy | 00.00% | View details for Guggenheim rating of Zevra Therapeutics (NASDAQ:ZVRA) on 8/7/2026 |
GENI Genius Sports | $8.04 +1.4% | 8/6/2026 | | Boost Price Target | $11.00 ➝ $12.00 | Buy | 00.00% | View details for Guggenheim rating of Genius Sports (NYSE:GENI) on 8/6/2026 |
ECG Everus Construction Group | $125.91 +0.5% | 8/6/2026 | | Boost Price Target | $160.00 ➝ $184.00 | Buy | 00.00% | View details for Guggenheim rating of Everus Construction Group (NYSE:ECG) on 8/6/2026 |
URGN Urogen Pharma | $46.86 +0.1% | 8/6/2026 | | Boost Price Target | $42.00 ➝ $58.00 | Buy | 00.00% | View details for Guggenheim rating of Urogen Pharma (NASDAQ:URGN) on 8/6/2026 |
SN SharkNinja | $181.26 +0.7% | 8/6/2026 | | Boost Price Target | $175.00 ➝ $210.00 | Buy | 00.00% | View details for Guggenheim rating of SharkNinja (NYSE:SN) on 8/6/2026 |
ACET Adicet Bio | $9.19 -2.0% | 8/6/2026 | | Reiterated Rating | $100.00 ➝ $90.00 | Buy | 00.00% | View details for Guggenheim rating of Adicet Bio (NASDAQ:ACET) on 8/6/2026 |
ARDT Ardent Health | $10.98 +4.8% | 8/6/2026 | | Boost Price Target | $13.00 ➝ $14.00 | Buy | 00.00% | View details for Guggenheim rating of Ardent Health (NYSE:ARDT) on 8/6/2026 |
ARQT Arcutis Biotherapeutics | $25.08 -1.1% | 8/6/2026 | | Boost Price Target | $35.00 ➝ $38.00 | Buy | 00.00% | View details for Guggenheim rating of Arcutis Biotherapeutics (NASDAQ:ARQT) on 8/6/2026 |
ELVN Enliven Therapeutics | $59.82 +1.5% | 8/6/2026 | | Lower Price Target | $80.00 ➝ $78.00 | Buy | 00.00% | View details for Guggenheim rating of Enliven Therapeutics (NASDAQ:ELVN) on 8/6/2026 |
PAYC Paycom Software | $229.37 +1.2% | 8/6/2026 | | Boost Price Target | $180.00 ➝ $225.00 | Buy | 00.00% | View details for Guggenheim rating of Paycom Software (NYSE:PAYC) on 8/6/2026 |
Your book attached (Ad) Bill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time through a temporary download link.
He plans to charge for it soon. Download your copy now and lock it in at no cost, regardless of future pricing. Download the Safe Trade Options Formula book for free before access closes |
JNJ Johnson & Johnson | $270.69 +1.2% | 8/6/2026 | | Boost Price Target | $270.00 ➝ $287.00 | Buy | 00.00% | View details for Guggenheim rating of Johnson & Johnson (NYSE:JNJ) on 8/6/2026 |
RVMD Revolution Medicines | $209.46 -1.1% | 8/6/2026 | | Boost Price Target | $235.00 ➝ $240.00 | Buy | 00.00% | View details for Guggenheim rating of Revolution Medicines (NASDAQ:RVMD) on 8/6/2026 |
DIS Walt Disney | $107.93 +0.6% | 8/6/2026 | | Reiterated Rating | $120.00 | Buy | 00.00% | View details for Guggenheim rating of Walt Disney (NYSE:DIS) on 8/6/2026 |
ONC BeOne Medicines | $374.47 +1.4% | 8/6/2026 | | Boost Price Target | $420.00 ➝ $430.00 | Buy | 00.00% | View details for Guggenheim rating of BeOne Medicines (NASDAQ:ONC) on 8/6/2026 |
PRIM Primoris Services | $77.17 -2.6% | 8/6/2026 | | Lower Price Target | $162.00 ➝ $127.00 | Buy | 00.00% | View details for Guggenheim rating of Primoris Services (NYSE:PRIM) on 8/6/2026 |
UBER Uber Technologies | $78.89 +0.4% | 8/6/2026 | | Reiterated Rating | $125.00 | Buy | 00.00% | View details for Guggenheim rating of Uber Technologies (NYSE:UBER) on 8/6/2026 |
MCD McDonald's | $270.84 +0.6% | 8/5/2026 | | Lower Price Target | $320.00 ➝ $290.00 | Neutral | 00.00% | View details for Guggenheim rating of McDonald’s (NYSE:MCD) on 8/5/2026 |
W Wayfair | $101.38 -1.9% | 8/5/2026 | | Boost Price Target | $100.00 ➝ $135.00 | Buy | 00.00% | View details for Guggenheim rating of Wayfair (NYSE:W) on 8/5/2026 |
TVTX Travere Therapeutics | $65.71 +1.9% | 8/5/2026 | | Boost Price Target | $65.00 ➝ $75.00 | Buy | 00.00% | View details for Guggenheim rating of Travere Therapeutics (NASDAQ:TVTX) on 8/5/2026 |
MRK Merck & Co., Inc. | $152.43 +2.3% | 8/5/2026 | | Boost Price Target | $145.00 ➝ $146.00 | Buy | 00.00% | View details for Guggenheim rating of Merck & Co., Inc. (NYSE:MRK) on 8/5/2026 |